Libya Blood Gas Analyzer and POC Immunoassay Analyzer Market Outlook to 2026F

The report titled “Libya Blood Gas Analyzer and POC Immunoassay Analyzer Market Outlook to 2026F – Rising demand of medical devices post-pandemic and reforming Healthcare Sector” provides a comprehensive analysis of the Diagnostic Equipments used in ICUs and NICUs. The report also covers an overview and genesis of the industry, product-wise market size in terms of the installed base; market segmentation by type of product, type of device, type of workload, type of sales model, type of hospital, type of region and by type of end-users; issues and challenges and comparative landscape including competition scenario, market shares of major brands based on Installed base, opportunities, and bottlenecks in Libya. The report concludes with future market projections of each product segmentation.


Libya Diagnostic Device Market (BGA and POC-IAA) Overview and Size:

Libya Diagnostic Device market to show a steady growth rate over the review period 2021-2026F supported by an increase in population in the country along with the transition of healthcare facilities from central lab devices to POC Devices. Improvement in healthcare infrastructure is also going to generate demand for such products in Libya.

Detailed Analysis of the Blood Gas Analyzer (BGA) Market:

Libya has a large installed base for blood gas analyzers owing to the presence of 97+ hospitals in the country. Libya BGA Market is an import-driven market, mainly importing from European countries, requiring registration and mandatory certificate from the Libya Ministry of Health. It is a concentrated market, largely occupied by Opti Medical and Radiometer devices. Most Devices in the market are Central Lab Devices.

Libya Blood Gas Analyzer (BGA) market is set to grow at a CAGR of 10.5% in terms of Installed base over the period 2021-2026F. Many Chinese, Japanese, and Korean companies are eyeing the Libya BGA Market as these devices are low in terms of price. Advancing technologies in the BGA market such as Portable equipment and AI for digital systems would help raise the sales volume.

Blood Gas Analyzer (BGA) Market Segmentations:

By Product: Central Lab Devices have dominated the market in terms of installations in 2021, due to the majority of tests being conducted in the hospitals.

By Sales Model and Workload: Consumable Model contributed the majority percentage share in terms of installations in 2021. BGA market has a low percentage for the outright sale model and high installation for Medium to High Sample Size Analyzers with government and private hospitals, which are offered by the benchtop devices such as CCA-TS2 series by Opti Medical.

By Type of End Users: Hospitals have a higher installed base over independent labs, specifically Government hospitals with >80% of the market captured in Libya since BGA has a higher testing demand for overnight admitted patients and such devices are required for patients in ICUs and NICUs.

Detailed Analysis of the Libya POC Immunoassay Analyzer (IAA) Market

POC Immunoassay Analyzer market is growing at a steady pace in Libya with major devices imported from European countries. It is a concentrated market with Boditech Med leading the market in Libya with high-quality devices, which are rich in features. There are other Chinese and Korean companies operating in the market. iChroma from Boditech Med is a popular choice for most end users.

POC IAA Market is expected to grow at a CAGR of 13.7% owing to technological advancements and standardizing protocols. Devices are advancing continuously in terms of size and operating parameters and are expected to see low maintenance and high-quality multi-parametric device in the future.

POC Immunoassay Analyzer (IAA) Market Segmentations:

By Product: POC Benchtop has slightly dominated the market in terms of installations in 2021. However, POC Handheld IAA is also becoming a popular choice.

By Sales Model: IAA market has a high percentage for the outright sale model. Since the device costs are low for POC-IAA in Libya hence, they are majorly sold through the outright model with variations in the no. of tests and types of tests conducted on each machine.

By Type of End users: Majority of the POC Immunoassay is sold via Tender based process fairly addressing both hospitals and clinics & independent labs as the end-users, with equivalent load in terms of tests in both private and public hospitals in Libya.

Key Segments Covered

Blood Gas Analyzer

By Installed Base

By Type of Product

By Type of Workload

By Type of Device

By type of Sales Model

By type of Hospital

By End User

POC Immunoassay Analyzer

By Installed Base

By Type of Product

By type of Sales Mode

By End User

Key Target Audience

Healthcare Industry

Medical Device Manufacturing Companies

Medical Device Distributors

Hospitals

Multi-specialty and Super Specialty Clinics

Diagnostic Centers

Sleep Labs Centers

Home Healthcare Centers

Time Period Captured in the Report:

Base Year: 2021

Forecast Period: 2022F–2026F

Companies Covered:

Equipment Manufacturers

Roche Diagnostics

Abbott

Siemens

Nova Biomedical

Radiometer

Medical

Opti Medical

Werfen

Edan

Key Topics Covered in the Report

• Libya Diagnostic Device (BGA and POC IAA) Introduction
• Market Ecosystem
• Value chain Analysis
• Major Challenges in Libya Diagnostic Device (BGA and POC IAA) Market
• Detailed Analysis of Blood Gas Analyzer Market in Libya (Market Size, 2021; Market Segmentation; Market Shares; Product Comparison; Competition; Future Market Size, 2026F)
• Detailed Analysis of Immunoassay Analyzer Market in Libya (Market Size, 2021; Market Segmentation; Market Shares; Product Comparison; Competition; Future Market Size, 2026F)